NASDAQ:OM Outset Medical (OM) Stock Price, News & Analysis $13.80 -0.40 (-2.85%) As of 01:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Outset Medical Stock (NASDAQ:OM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Outset Medical alerts:Sign Up Key Stats Today's Range$13.63▼$14.0250-Day Range$12.43▼$20.9052-Week Range$5.85▼$25.35Volume25,397 shsAverage Volume225,337 shsMarket Capitalization$245.15 millionP/E RatioN/ADividend YieldN/APrice Target$24.67Consensus RatingBuy Company Overview Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Read More Outset Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks30th Percentile Overall ScoreOM MarketRank™: Outset Medical scored higher than 30% of companies evaluated by MarketBeat, and ranked 792nd out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingOutset Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageOutset Medical has only been the subject of 2 research reports in the past 90 days.Read more about Outset Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Outset Medical is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Outset Medical is -0.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOutset Medical has a P/B Ratio of 1.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Outset Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.72% of the float of Outset Medical has been sold short.Short Interest Ratio / Days to CoverOutset Medical has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Outset Medical has recently decreased by 1.37%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOutset Medical does not currently pay a dividend.Dividend GrowthOutset Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted12.72% of the float of Outset Medical has been sold short.Short Interest Ratio / Days to CoverOutset Medical has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Outset Medical has recently decreased by 1.37%, indicating that investor sentiment is improving. News and Social Media1.9 / 5News Sentiment0.46 News SentimentOutset Medical has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Outset Medical this week, compared to 4 articles on an average week.Search InterestOnly 2 people have searched for OM on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Outset Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.40% of the stock of Outset Medical is held by insiders.Read more about Outset Medical's insider trading history. Receive OM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address OM Stock News HeadlinesOutset Medical's (OM) Sector Perform Rating Reaffirmed at Royal Bank Of CanadaAugust 21, 2025 | americanbankingnews.comOutset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare ConferenceAugust 20, 2025 | globenewswire.comGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—not the government—have been handed control of a new class of programmable money. It’s not called a CBDC, but it acts just like one. Your spending could be tracked, limited, or even frozen—whether you opt in or not. Once this system becomes the default, escape won’t be easy.August 25 at 2:00 AM | Priority Gold (Ad)Outset Medical’s Earnings Call Highlights Strong GrowthAugust 15, 2025 | theglobeandmail.comOutset Medical Inc.August 15, 2025 | barrons.comOutset Medical (OM) Receives a Hold from OppenheimerAugust 15, 2025 | theglobeandmail.comOutset Medical Reports Strong Q2 Growth and Raises GuidanceAugust 7, 2025 | msn.comWhat To Expect From Outset Medical Inc (OM) Q2 2025 EarningsAugust 7, 2025 | finance.yahoo.comSee More Headlines OM Stock Analysis - Frequently Asked Questions How have OM shares performed this year? Outset Medical's stock was trading at $16.65 at the beginning of the year. Since then, OM shares have decreased by 17.1% and is now trading at $13.7960. How were Outset Medical's earnings last quarter? Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings results on Wednesday, May, 7th. The company reported ($3.66) EPS for the quarter, missing the consensus estimate of ($0.97) by $2.69. The company earned $29.75 million during the quarter, compared to the consensus estimate of $27.81 million. Outset Medical had a negative trailing twelve-month return on equity of 97.17% and a negative net margin of 82.06%. Read the conference call transcript. When did Outset Medical's stock split? Outset Medical shares reverse split before market open on Thursday, March 20th 2025.The 1-15 reverse split was announced on Tuesday, March 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, March 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Outset Medical IPO? Outset Medical (OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and SVB Leerink and Stifel were co-managers. Who are Outset Medical's major shareholders? Outset Medical's top institutional investors include Durable Capital Partners LP (9.33%), Marshall Wace LLP (2.93%), Pura Vida Investments LLC (2.41%) and Geode Capital Management LLC (2.35%). Insiders that own company stock include Leslie Trigg, Steven S Williamson, Jean-Olivier Racine, Nabeel Ahmed, Marc Nash, John L Brottem, Martin Vazquez, Stacey L Porter and D Keith Grossman. View institutional ownership trends. How do I buy shares of Outset Medical? Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Outset Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Outset Medical investors own include Pinterest (PINS), Shopify (SHOP), Trade Desk (TTD), Fiverr International (FVRR), Teladoc Health (TDOC), Lemonade (LMND) and Company Calendar Last Earnings5/07/2025Today8/25/2025Next Earnings (Estimated)11/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNASDAQ:OM CIK1484612 Weboutsetmedical.com Phone669-231-8200FaxN/AEmployees520Year FoundedN/APrice Target and Rating Average Price Target for Outset Medical$24.67 High Price Target$37.00 Low Price Target$15.00 Potential Upside/Downside+73.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($20.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$127.98 million Net Margins-82.06% Pretax Margin-81.73% Return on Equity-97.17% Return on Assets-32.84% Debt Debt-to-Equity Ratio0.63 Current Ratio7.47 Quick Ratio6.05 Sales & Book Value Annual Sales$113.69 million Price / Sales2.22 Cash FlowN/A Price / Cash FlowN/A Book Value$7.49 per share Price / Book1.90Miscellaneous Outstanding Shares17,770,000Free Float17,340,000Market Cap$252.33 million OptionableNot Optionable Beta2.14 Social Links 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:OM) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outset Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outset Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.